Riccardo Nevola
Riccardo Nevola
Internal Medicine - University of Campania "Luigi Vanvitelli"
Verified email at
Cited by
Cited by
Chronic hepatitis C virus infection and neurological and psychiatric disorders: an overview
LE Adinolfi, R Nevola, G Lus, L Restivo, B Guerrera, C Romano, ...
World journal of gastroenterology: WJG 21 (8), 2269, 2015
The importance of telemedicine during COVID-19 pandemic: a focus on diabetic retinopathy
R Galiero, PC Pafundi, R Nevola, L Rinaldi, C Acierno, A Caturano, ...
Journal of diabetes research 2020, 2020
Hepatitis C virus eradication by direct-acting antiviral agents improves carotid atherosclerosis in patients with severe liver fibrosis
S Petta, LE Adinolfi, AL Fracanzani, F Rini, R Caldarella, V Calvaruso, ...
Journal of Hepatology 69 (1), 18-24, 2018
Efficacy and durability of multifactorial intervention on mortality and MACEs: A randomized clinical trial in type-2 diabetic kidney disease
FC Sasso, PC Pafundi, V Simeon, L De Nicola, P Chiodini, R Galiero, ...
Cardiovascular Diabetology 20, 1-12, 2021
Impact of hepatitis C virus clearance by direct-acting antiviral treatment on the incidence of major cardiovascular events: A prospective multicentre study
LE Adinolfi, S Petta, AL Fracanzani, C Coppola, V Narciso, R Nevola, ...
Atherosclerosis 296, 40-47, 2020
Hepatitis C virus clearance by direct‐acting antiviral treatments and impact on insulin resistance in chronic hepatitis C patients
LE Adinolfi, R Nevola, B Guerrera, G D'Alterio, A Marrone, M Giordano, ...
Journal of gastroenterology and hepatology 33 (7), 1379-1382, 2018
Chronic hepatitis C virus infection and depression
LE Adinolfi, R Nevola, L Rinaldi, C Romano, M Giordano
Clinics in liver disease 21 (3), 517-534, 2017
Metformin: An old drug against old age and associated morbidities
T Salvatore, PC Pafundi, F Morgillo, R Di Liello, R Galiero, R Nevola, ...
Diabetes Research and Clinical Practice 160, 108025, 2020
Risk of hepatocellular carcinoma after HCV clearance by direct-acting antivirals treatment predictive factors and role of epigenetics
L Rinaldi, R Nevola, G Franci, A Perrella, G Corvino, A Marrone, ...
Cancers 12 (6), 1351, 2020
Reduced incidence of type 2 diabetes in patients with chronic hepatitis C virus infection cleared by direct‐acting antiviral therapy: a prospective study
LE Adinolfi, S Petta, AL Fracanzani, R Nevola, C Coppola, V Narciso, ...
Diabetes, Obesity and Metabolism 22 (12), 2408-2416, 2020
Non-alcoholic fatty liver disease: From pathogenesis to clinical impact
A Caturano, C Acierno, R Nevola, PC Pafundi, R Galiero, L Rinaldi, ...
Processes 9 (1), 135, 2021
A review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy
C Mazzaro, L Quartuccio, LE Adinolfi, D Roccatello, G Pozzato, R Nevola, ...
Viruses 13 (11), 2249, 2021
Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: A prospective multicentre study
L Rinaldi, A Perrella, M Guarino, M De Luca, G Piai, N Coppola, ...
Journal of Translational Medicine 17, 1-10, 2019
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis
L Rinaldi, F Nascimbeni, M Giordano, C Masetti, B Guerrera, A Amelia, ...
World Journal of Gastroenterology 23 (8), 1458, 2017
Metformin lactic acidosis: Should we still be afraid?
T Salvatore, PC Pafundi, R Marfella, C Sardu, L Rinaldi, L Monaco, ...
Diabetes Research and Clinical Practice 157, 107879, 2019
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study
R Galiero, PC Pafundi, V Simeon, L Rinaldi, A Perrella, E Vetrano, ...
PloS one 15 (12), e0243700, 2020
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes
FC Sasso, PC Pafundi, A Caturano, R Galiero, E Vetrano, R Nevola, ...
Nutrition, Metabolism and Cardiovascular Diseases 31 (8), 2345-2353, 2021
Role of liver stiffness measurement in predicting HCC occurrence in direct-acting antivirals setting: a real-life experience
L Rinaldi, M Guarino, A Perrella, PC Pafundi, G Valente, L Fontanella, ...
Digestive diseases and sciences 64, 3013-3019, 2019
GLP-1 receptor agonists in non-alcoholic fatty liver disease: current evidence and future perspectives
R Nevola, R Epifani, S Imbriani, G Tortorella, C Aprea, R Galiero, ...
International Journal of Molecular Sciences 24 (2), 1703, 2023
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc …
FC Sasso, V Simeon, R Galiero, A Caturano, L De Nicola, P Chiodini, ...
Cardiovascular Diabetology 21 (1), 235, 2022
The system can't perform the operation now. Try again later.
Articles 1–20